Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 7, 2024; 30(5): 471-484
Published online Feb 7, 2024. doi: 10.3748/wjg.v30.i5.471
Published online Feb 7, 2024. doi: 10.3748/wjg.v30.i5.471
Figure 2 The expression of let-7a-5p is depressed using anti-let-7a-5p sponges delivered by recombinant adeno-associated virus 8.
A: The recombinant adeno-associated virus 8 was extensively distributed in the liver of mice after 2 or 6 wk of 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine (DDC) feeding; B and C: The relative expression of GFP indicates the relative amounts of virus; D and E: The relative expression of let-7a-5p in the liver of mice injected by adeno-associated virus 8-mediated scramble control or anti-let-7a-5p sponges after 2 wk or 6 wk of DDC feeding. DDC: 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine; SCR: Scramble control. bP < 0.01, cP < 0.001.
- Citation: Hua H, Zhao QQ, Kalagbor MN, Yu GZ, Liu M, Bian ZR, Zhang BB, Yu Q, Xu YH, Tang RX, Zheng KY, Yan C. Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model. World J Gastroenterol 2024; 30(5): 471-484
- URL: https://www.wjgnet.com/1007-9327/full/v30/i5/471.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i5.471